Exome-based cancer driver gene comprehensive testing can provide a genetic diagnosis for individuals with triple-negative breast cancer

Daniel Alzate, Angel Yobany Sánchez, Yovana Pacheco, Mario Isaza Ruget, Ramiro Sánchez, Carolina Castillo, Carlos A Parra-López · 2026

Read Exome-based cancer driver gene comprehensive testing can provide a genetic diagnosis for individuals with triple-negative breast cancer by Daniel Alzate, Angel Yobany Sánchez, Yovana Pacheco, Mario Isaza Ruget, Ramiro Sánchez, Carolina Castillo, Carlos A Parra-López (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0356762.txt.

Description

Daniel Alzate and colleagues validated a whole-exome sequencing pipeline that can diagnose inherited cancer risk in triple-negative breast cancer patients straight from the same test used on their tumors. Their 2026 study built a curated panel of cancer susceptibility genes, proved the pipeline on twenty-five patients with already-confirmed hereditary diagnoses, then applied it to twenty-four triple-negative patients.

One patient in eight in the discovery group carried a harmful inherited variant, landing in three genes that all serve the cell's main DNA repair pathway. The result matters clinically: such diagnoses change a patient's own treatment and trigger testing for relatives. The authors show a single exome test can carry both jobs, tumor profiling and germline answers.

Catalog record

CREATORDaniel Alzate, Angel Yobany Sánchez, Yovana Pacheco, Mario Isaza Ruget, Ramiro Sánchez, Carolina Castillo, Carlos A Parra-López
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE33752
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0356762

Browse the full library · About the Tower of Babel